The Feinstein Institutes for Medical Research, home of the research institutes of New York’s Northwell Health, announced it has received a five-year, $2.9 million grant from the National Institutes of Health to investigate the potential of human ghrelin, a naturally occurring hormone, as a medical countermeasure against radiation-induced gastrointestinal syndrome (GI-ARS).

A new report from the National Academies of Sciences, Engineering, and Medicine (NASEM) estimates that $100 million annually will be required for the next 15 years to develop a coordinated research program led by the Department of Energy and the National Institutes of Health to study how low doses of radiation affect disease risk. The recommended research would investigate causal links to specific health conditions and better define the impacts of radiation doses, dose rates, types of radiation, and exposure duration.